Literature DB >> 9607007

Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: impact of epitope orientation.

N Ahlborg1, E H Nardin, P Perlmann, K Berzins, R Andersson.   

Abstract

Assembly of B and T epitopes in multiple antigen peptides (MAP) can bypass genetically predisposed unresponsiveness to B epitopes. Although the underlying mechanisms are unknown, B-cell responses to such diepitope MAP are influenced by intramolecular epitope orientation. In this study, MAP constructs were synthesized, encompassing two epitopes derived from the Plasmodium falciparum antigens circumsporozoite protein (CS) and Pf332. In addition to B epitopes, the sequences comprised T epitopes restricted to mouse H-2b (CS) or to H-2d and H-2k (Pf332) haplotypes. Congenic H-2b, H-2d and H-2k Balb mice were immunized with MAP in which the two epitopes were arranged either tandemly or in parallel. Tandemly arranged (B-T)4 MAP, in which the relevant T epitope was positioned adjacent to the lysine core [(Pf332-CS)4-core for H-2b mice and (CS-Pf332)4-core for H-2d and H-2k mice], elicited the most potent antibody responses in terms of reactivity to both epitopes. Additionally, the (B-T)4 constructs were generally most efficient in recalling proliferative T-cell responses in vitro, irrespective of the MAP used for in vivo priming. As high antibody titers were generated to both epitopes, the position of B epitopes in the constructs does not appear to be critical for an efficient B-cell response. Rather, the association of strong B- and T-cell responses to the (B-T)4 MAP constructs suggests that the intramolecular position of the relevant T epitope determines the magnitude of specific antibody production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607007     DOI: 10.1016/s0264-410x(97)00155-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.

Authors:  M B Joshi; A A Gam; R A Boykins; S Kumar; J Sacci; S L Hoffman; H L Nakhasi; R T Kenney
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  O-GlcNAc modification of the anti-malarial vaccine candidate PfAMA1: in silico-defined structural changes and potential to generate a better vaccine.

Authors:  Nasir Uddin; Daniel C Hoessli; Asma Butt; Afshan Kaleem; Zeeshan Iqbal; Imran Afzal; Zahra Zamani; Abdul Rauf Shakoori
Journal:  Mol Biol Rep       Date:  2011-10-22       Impact factor: 2.316

3.  Characterization of a branched lipopeptide candidate vaccine against influenza A/Puerto Rico 8/34 which is recognized by human B and T-cell immune responses.

Authors:  Liz Samayoa; Francisco Diaz-Mitoma; Ali Azizi
Journal:  Virol J       Date:  2011-06-16       Impact factor: 4.099

4.  Enhanced immunogenicity of a functional enzyme by T cell epitope modification.

Authors:  Jeanette M Mucha; Marcia M Stickler; A J Poulose; Grant Ganshaw; Mae Saldajeno; Kathy Collier; Manley T Huang; Fiona A Harding
Journal:  BMC Immunol       Date:  2002-01-25       Impact factor: 3.615

5.  A Scalable Manufacturing Approach to Single Dose Vaccination against HPV.

Authors:  Shuai Shao; Oscar A Ortega-Rivera; Sayoni Ray; Jonathan K Pokorski; Nicole F Steinmetz
Journal:  Vaccines (Basel)       Date:  2021-01-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.